Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
about
Clinical application of a 3D ultrasound-guided prostate biopsy systemLimitations and Prospects for Diffusion-Weighted MRI of the ProstateAdded value of diffusion-weighted acquisitions in MRI of the abdomen and pelvisDiffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshopDiffusion weighted imaging in prostate cancer.The expanding landscape of diffusion-weighted MRI in prostate cancerAssessment of Prostate Cancer Aggressiveness by Use of the Combination of Quantitative DWI and Dynamic Contrast-Enhanced MRI.A new phantom and empirical formula for apparent diffusion coefficient measurement by a 3 Tesla magnetic resonance imaging scanner.Prostate cancer metabolite quantification relative to water in 1H-MRSI in vivo at 3 Tesla.Monitoring the development of xenograft triple-negative breast cancer models using diffusion-weighted magnetic resonance imaging.16 T diffusion microimaging of fixed prostate tissue: preliminary findings.Microscopic diffusion anisotropy in formalin fixed prostate tissue: preliminary findings.Molecular imaging of water binding state and diffusion in breast cancer using diffuse optical spectroscopy and diffusion weighted MRIIs apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?Accelerated T2 mapping for characterization of prostate cancer.Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.High-field small animal magnetic resonance oncology studies.Predicting Prostate Biopsy Outcomes: A Preliminary Investigation on Screening with Ultrahigh B-Value Diffusion-Weighted Imaging as an Innovative Diagnostic Biomarker.Integration of DCE-MRI and DW-MRI Quantitative Parameters for Breast Lesion ClassificationEvaluating Prostate Cancer Using Fractional Tissue Composition of Radical Prostatectomy Specimens and Pre-Operative Diffusional Kurtosis Magnetic Resonance ImagingINNOVATE: A prospective cohort study combining serum and urinary biomarkers with novel diffusion-weighted magnetic resonance imaging for the prediction and characterization of prostate cancerDiffusion-weighted MRI for detecting prostate tumour in men at increased genetic risk.Diffusion-Weighted Imaging in Meningioma: Prediction of Tumor Grade and Association with Histopathological Parameters.Assessing Detection, Discrimination, and Risk of Breast Cancer According to Anisotropy Parameters of Diffusion Tensor ImagingTransatlantic Consensus Group on active surveillance and focal therapy for prostate cancerImaging and Markers as Novel Diagnostic Tools in Detecting Insignificant Prostate Cancer: A Critical OverviewEvaluation of Nonradiative Clinical Imaging Techniques for the Longitudinal Assessment of Tumour Growth in Murine CT26 Colon Carcinoma.Characterization of gradient echo signal decays in healthy and cancerous prostate at 3T improves with a Gaussian augmentation of the mono-exponential (GAME) modelThe correlation between apparent diffusion coefficient and tumor cellularity in patients: a meta-analysis.Pilot Study of the Use of Hybrid Multidimensional T2-Weighted Imaging-DWI for the Diagnosis of Prostate Cancer and Evaluation of Gleason Score.Oncologic applications of diffusion-weighted MRI in the body.Prebiopsy magnetic resonance spectroscopy and imaging in the diagnosis of prostate cancer.Multiparametric MRI of prostate cancer: an update on state-of-the-art techniques and their performance in detecting and localizing prostate cancer.Role of high-field MR in studies of localized prostate cancer.Computer-aided Detection of Prostate Cancer with MRI: Technology and Applications.Intratumor Heterogeneity of Perfusion and Diffusion in Clear-Cell Renal Cell Carcinoma: Correlation With Tumor Cellularity.Risk stratification of prostate cancer utilizing apparent diffusion coefficient value and lesion volume on multiparametric MRI.Diffusion-weighted MRI in Crohn's disease: Current status and recommendations.Quantitative diffusion-weighted imaging and dynamic contrast-enhanced characterization of the index lesion with multiparametric MRI in prostate cancer patients.Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.
P2860
Q24608010-3CEEC8AD-CE81-4956-948D-015907B3CC6AQ26744802-C3670D16-9D5B-45C9-97C6-9C1BBD1137DFQ27021440-00E2298C-05A2-4F8A-9B43-8ED3DA6714BCQ28079278-2C718F64-5570-47EE-BFE7-09772E71155DQ33714805-8E23FCD6-2AF0-42FF-92D8-40CACBD74998Q33762501-8D4F1413-EC3A-4484-A45A-2D48644A5A76Q33821885-FC69D014-7D41-4C38-BBA9-069C7C164E97Q33844035-7E388F96-08F5-4197-A87E-CA8EC1D0DBFAQ33849173-0359A0F8-8022-4AF1-B604-46D1CE27F108Q33882146-31A9B5D5-7811-4E8F-B9C9-5CF790782207Q33939925-AE6C5864-8AA9-42FC-8D65-BE863DD208D8Q34144375-C258E6A1-B76C-46CD-89FB-C5F9A441DBADQ34380422-2C4FCBF2-9C7D-411E-BE3A-DD4B7BE02CE6Q34534796-6A9C6233-2FE4-4499-9A18-F14A4ACB9FDDQ34810427-60164505-16DD-491C-BD78-290888AD9ECEQ34995967-0CF2812C-5F86-4FF4-8120-D711F7466ABAQ35312455-2106F5F1-493C-45D7-B841-7047D83D896FQ35952787-886F829B-8537-438D-A852-AD503B4AAAE8Q35960422-7C6401B7-3E3A-4B2E-B35B-96CF0F79E458Q36088325-C0B81A05-4F7D-46AE-96BB-B676429D431BQ36171334-3F4D9676-7E5C-4453-8054-42BFD7F77F93Q36394012-69C9358A-7A7E-49C0-8CE3-194F82E969CBQ36427527-02498C9B-032C-4116-924D-8D8B76C2BCCDQ36826701-8C1E8831-4BD7-4340-B7F0-E2209FAD642BQ36928846-443A9A6C-9C27-4830-9724-E47AF238145DQ36979944-63212591-6548-4C20-AEB1-8C540F51C3DEQ37019989-A38AE5D7-E080-4945-A357-456CEC827A8EQ37118580-515B504C-DE24-4BE5-AED9-B5EBB5A19703Q37297789-099CBEFF-D09B-4245-9F49-DBB18483841FQ37357815-2E4358BF-9546-42DE-9A68-F98DDF11E74CQ37978220-083CCC09-2087-4653-8046-C6E883AA3E85Q37995646-06C8752C-C03E-48CE-BE64-7393C1A7B76CQ38100740-48760292-BAE8-41F0-ACB6-BEFA9A69B8B2Q38109111-8A63B1D7-9552-4628-BAD1-A4C0F358555CQ38822172-F2356696-629C-4B3B-8422-B9F63AD8D5F9Q38840914-74CA0901-BF39-4B5D-A4F1-5B4332D074C5Q38842683-AB682224-5E56-4682-91D2-00404FEACDBDQ38850083-B24E23B8-098F-4A2E-85FE-D989329FECBCQ38904161-2A13FF12-5BDF-497E-8452-71AEB529AB28Q38967177-CFCB9183-8C64-4651-A43E-9EE2C9036826
P2860
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
@en
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
@nl
type
label
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
@en
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
@nl
prefLabel
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
@en
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
@nl
P2093
P1476
Correlation of ADC and T2 measurements with cell density in prostate cancer at 3.0 Tesla.
@en
P2093
Bashar Zelhof
Gary P Liney
Greta Rodrigues
Lindsay W Turnbull
Martin D Pickles
Peter Gibbs
P304
P356
10.1097/RLI.0B013E3181B4C10E
P577
2009-09-01T00:00:00Z